Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
19906 | 484 | 26.4 | 55% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY | 4064930 |
316 | 3 | RHEUMATOLOGY//RHEUMATOID ARTHRITIS//RHEUMATOL | 39766 |
1684 | 2 | METHOTREXATE//FOLATE RECEPTOR//REDUCED FOLATE CARRIER | 6769 |
19906 | 1 | TENIDAP//SULFASALAZINE//SULPHASALAZINE | 484 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | TENIDAP | authKW | 730165 | 5% | 46% | 25 |
2 | SULFASALAZINE | authKW | 474380 | 12% | 13% | 57 |
3 | SULPHASALAZINE | authKW | 262837 | 4% | 21% | 20 |
4 | TENIDAP SODIUM | authKW | 157716 | 1% | 50% | 5 |
5 | 2ND LINE AGENT | authKW | 126177 | 0% | 100% | 2 |
6 | SALAZOSULFAPYRIDINE | authKW | 68567 | 1% | 22% | 5 |
7 | 2 6 DIMETHYLBENZAMIDE N 5 METHYL 3 ISOXAZOLYL | authKW | 63089 | 0% | 100% | 1 |
8 | 2 6 DIMETHYLBENZOIC ACID ALPHA C 14 | authKW | 63089 | 0% | 100% | 1 |
9 | 2 6 DIMETHYLBENZOIC ACID HALIDE ALPHA C 14 | authKW | 63089 | 0% | 100% | 1 |
10 | 239B VICTORIA HALL | address | 63089 | 0% | 100% | 1 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Rheumatology | 41038 | 53% | 0% | 255 |
2 | Pharmacology & Pharmacy | 332 | 17% | 0% | 84 |
3 | Medicine, General & Internal | 263 | 12% | 0% | 59 |
4 | Gastroenterology & Hepatology | 52 | 4% | 0% | 19 |
5 | Toxicology | 40 | 4% | 0% | 17 |
6 | Immunology | 19 | 5% | 0% | 24 |
7 | Medicine, Research & Experimental | 9 | 3% | 0% | 14 |
8 | Pediatrics | 4 | 2% | 0% | 10 |
9 | Medicine, Legal | 0 | 0% | 0% | 1 |
10 | Medical Laboratory Technology | 0 | 0% | 0% | 2 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | 239B VICTORIA HALL | 63089 | 0% | 100% | 1 |
2 | IMMUNOL INFECT DIS CENT | 63089 | 0% | 100% | 1 |
3 | L SACCO HOSP MILANO ITALY | 63089 | 0% | 100% | 1 |
4 | MICROBIOL VIROL UO | 63089 | 0% | 100% | 1 |
5 | PHARM PHARM PRACTICE3500 VICTORIA ST | 63089 | 0% | 100% | 1 |
6 | RHEUMATOL UOC | 63089 | 0% | 100% | 1 |
7 | SERV MED INTERNE PR ROUVEIX 2 | 63089 | 0% | 100% | 1 |
8 | H USSHEIM RHEUMATOL | 31543 | 0% | 50% | 1 |
9 | OBSTETGYNECOL REPROD SCI | 31543 | 0% | 50% | 1 |
10 | MICROBIOL CHAIR | 21028 | 0% | 33% | 1 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | BRITISH JOURNAL OF RHEUMATOLOGY | 60425 | 10% | 2% | 46 |
2 | SCANDINAVIAN JOURNAL OF RHEUMATOLOGY | 18008 | 6% | 1% | 29 |
3 | ANNALS OF THE RHEUMATIC DISEASES | 12516 | 9% | 0% | 42 |
4 | JOURNAL OF RHEUMATOLOGY | 8722 | 9% | 0% | 42 |
5 | REVUE DU RHUMATISME | 5412 | 3% | 1% | 14 |
6 | ZEITSCHRIFT FUR RHEUMATOLOGIE | 3879 | 2% | 1% | 12 |
7 | RHEUMATOLOGY AND REHABILITATION | 1937 | 0% | 2% | 2 |
8 | DRUGS | 1884 | 3% | 0% | 13 |
9 | CLINICAL RHEUMATOLOGY | 1688 | 2% | 0% | 12 |
10 | CLINICAL AND EXPERIMENTAL RHEUMATOLOGY | 1373 | 2% | 0% | 11 |
Author Key Words |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | RAINS, CP , NOBLE, S , FAULDS, D , (1995) SULFASALAZINE - A REVIEW OF ITS PHARMACOLOGICAL PROPERTIES AND THERAPEUTIC EFFICACY IN THE TREATMENT OF RHEUMATOID-ARTHRITIS.DRUGS. VOL. 50. ISSUE 1. P. 137-156 | 59 | 57% | 53 |
2 | BOX, SA , PULLAR, T , (1997) SULPHASALAZINE IN THE TREATMENT OF RHEUMATOID ARTHRITIS.BRITISH JOURNAL OF RHEUMATOLOGY. VOL. 36. ISSUE 3. P. 382-386 | 29 | 59% | 21 |
3 | PORTER, DR , CAPELL, HA , (1990) THE USE OF SULFASALAZINE AS A DISEASE MODIFYING ANTIRHEUMATIC DRUG.BAILLIERES CLINICAL RHEUMATOLOGY. VOL. 4. ISSUE 3. P. 535-557 | 32 | 65% | 15 |
4 | PULLAR, T , (1992) ADVERSE-EFFECTS OF SULFASALAZINE.ADVERSE DRUG REACTIONS AND TOXICOLOGICAL REVIEWS. VOL. 11. ISSUE 2. P. 93-109 | 32 | 58% | 11 |
5 | DEBIAIS, F , AZAIS, I , BOIFFARD, O , VINCENT, MH , ALCALAY, M , BONTOUX, D , (1989) TREATMENT OF RHEUMATOID POLYARTHRITIS WITH SALAZOSULFAPYRIDINE - REPORT OF 23 CASES.REVUE DU RHUMATISME. VOL. 56. ISSUE 10. P. 665-669 | 23 | 92% | 1 |
6 | CHALMERS, IM , SITAR, DS , HUNTER, T , (1990) A ONE-YEAR, OPEN, PROSPECTIVE-STUDY OF SULFASALAZINE IN THE TREATMENT OF RHEUMATOID-ARTHRITIS - ADVERSE REACTIONS AND CLINICAL-RESPONSE IN RELATION TO LABORATORY VARIABLES, DRUG AND METABOLITE SERUM LEVELS, AND ACETYLATOR STATUS.JOURNAL OF RHEUMATOLOGY. VOL. 17. ISSUE 6. P. 764-770 | 20 | 95% | 24 |
7 | ASCH, L , AYROLLES, C , BARDET, M , BARDIN, T , BONTOUX, D , BOUVIER, M , BREGEON, C , CROUZET, J , DESHAYES, P , FOURNIE, A , ET AL (1992) SULFASALAZINE FOR THE TREATMENT OF RHEUMATOID-ARTHRITIS.REVUE DU RHUMATISME. VOL. 59. ISSUE 11. P. 707-713 | 21 | 84% | 0 |
8 | KITAS, GD , FARR, M , WATERHOUSE, L , BACON, PA , (1992) INFLUENCE OF ACETYLATOR STATUS ON SULFASALAZINE EFFICACY AND TOXICITY IN PATIENTS WITH RHEUMATOID-ARTHRITIS.SCANDINAVIAN JOURNAL OF RHEUMATOLOGY. VOL. 21. ISSUE 5. P. 220-225 | 16 | 100% | 20 |
9 | PULLAR, T , (1989) SULPHASALAZINE AND RELATED DRUGS IN RHEUMATOID-ARTHRITIS.PHARMACOLOGY & THERAPEUTICS. VOL. 42. ISSUE 3. P. 459-468 | 28 | 67% | 9 |
10 | SENTURK, T , AYDINTUG, AO , DUZGUN, N , TOKGOZ, G , (1997) SEIZURES AND HEPATOTOXICITY FOLLOWING SULPHASALAZINE ADMINISTRATION.RHEUMATOLOGY INTERNATIONAL. VOL. 17. ISSUE 2. P. 75-77 | 13 | 100% | 10 |
Classes with closest relation at Level 1 |